Diskussionsleiter: G. Frommeyer (Münster), E. P. Scholz (Heidelberg)
| (P1084) | Cardiac pacemaker cell-specific characteristics of differentiated human mesenchymal stem cells | |
| F. F. Darche, R. Rivinius, M. Koenen, D. Thomas, H. A. Katus, P. Schweizer (Heidelberg) | ||
| (P1085) | Implantable Cardioverter-Defibrillator therapy in children: 20-year single center experience | |
| M. Bettin, S. Feder, V. Debus, F. Reinke, A. Löher, J. Köbe, H.-G. Kehl, L. Eckardt (Münster) | ||
| (P1086) | The role of the NLRP3 inflammasome in postoperative atrial fibrillation | |
| T. Veleva, N. Li, I. Abu-Taha, C. Schmidt, M. Kamler, X. Wehrens, J. Heijman, S. Nattel, D. Dobrev (Essen; Houston, US; Maastricht, NL; Montreal, CA) | ||
| (P1087) | Oxytocin and prolactin prolong cardiac repolarization in long QT syndrome type 2 by altering KCNQ1/IKs, Cav1.2 and RyR2 expression and function | |
| I. Bodi, J. Sorge, S. Glatz, A. Castiglione, G. Franke, S. Perez-Feliz, G. Koren, M. Zehender, M. Brunner, C. Bode, K. Odening (Freiburg; Providence, US) | ||
| (P1088) | Stretch-activated channels in human atrial fibroblasts: identification and regulation during atrial fibrillation | |
| A. Klesen, D. Jakob, P. Kohl, U. Ravens, R. Peyronnet (Freiburg im Breisgau) | ||
| (P1089) | Acute proarrhythmic effect of aliskiren in an experimental model of atrial fibrillation | |
| C. Ellermann, A. Mittelstedt, F. Güner, P. Niehues, K. Wasmer, P. S. Lange, L. Eckardt, G. Frommeyer (Münster) |